BC
WVE icon

Boxer Capital’s Wave Life Sciences WVE Stock Holding History

Boxer Capital’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-1,000,000
Closed -$20.5M – 58
2019
Q3 		$20.5M Hold
1,000,000
– – 1.49% 21
2019
Q2 		$26.1M Hold
1,000,000
– – 2.24% 16
2019
Q1 		$38.9M Sell
1,000,000
-650,000
-39% -$26.4M 4.49% 9
2018
Q4 		$69.4M Buy
1,650,000
+59,400
+4% +$2.64M 8.57% 4
2018
Q3 		$79.5M Hold
1,590,600
– – 8.83% 4
2018
Q2 		$60.8M Buy
1,590,600
+240,600
+18% +$10.4M 6.89% 6
2018
Q1 		$54.1M Buy
1,350,000
+800,000
+145% +$33.6M 5.77% 7
2017
Q4 		$19.3M Buy
+550,000
New +$16M 3.53% 10

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Boxer Capital's WVE Position: Q4 2019 in Review

Boxer Capital sold out of Wave Life Sciences (WVE) in Q4 2019, closing a stake of 1,000,000 shares — an estimated $20.5M sold.

Boxer Capital first reported a position in WVE in Q4 2017 and held it in 8 quarters. The position peaked at $79.5M in Q3 2018. 90 funds tracked by Wall St. Rank hold WVE as of Q4 2019.

  • Boxer Capital reported no remaining Wave Life Sciences position as of Q4 2019 after selling out during the quarter.
  • Boxer Capital sold 1,000,000 Wave Life Sciences shares in Q4 2019, an estimated $20.5M.
  • Boxer Capital first reported a position in Wave Life Sciences in Q4 2017 and held it in 8 quarters.
  • Boxer Capital's Wave Life Sciences position peaked at $79.5M in Q3 2018.
  • 90 funds tracked by Wall St. Rank held Wave Life Sciences as of Q4 2019.

Based on Boxer Capital's 13F filing for Q4 2019, filed 14 Feb 2020.